Return to search

IPO Profile: Immune Design Corp

Company Details

Location: 1616 Eastlake Avenue East, Seattle, Washington 98102

Phone: (206) 682-0645

Website: http://www.immunedesign.com

Business Description: Immunotherapy company with in vivo approaches designed to fight disease

Investment & Return Details

VC backers: Alta Partners, Column Group, ProQuest Investments, Topspin Partners LP, Versant Ventures, Inc.

Investment Dates: 06/04/2008, 06/24/2009, 10/05/2009, 01/05/2010, 07/23/2010, 09/21/2011, 11/15/2012, 10/30/2013, 05/21/2014

Total Funding To Date (USD Mil): $108.85

Value of VCs’ shares at IPO price (USD Mil): $1,023.31

Total return to VCs at IPO price: 9.4x

Shares Beneficially owned by VCs at Offering:

  • Alta Partners: 17,847,824
  • Column Group: 22,586,954
  • ProQuest Investments: 20,543,476
  • Topspin Partners LP: 6,450,000
  • Versant Ventures, Inc: 17,847,824
  • Total: 85,276,078

Value of VC shares at IPO price (USD Mil):

  • Alta Partners: $214.17
  • Column Group: $271.04
  • ProQuest Investments: $246.52
  • Topspin Partners LP: $77.4
  • Versant Ventures, Inc: $214.17
  • Total: $1,023.31

IPO Details

Primary Exchange: Nasdaq

Ticker: IMDZ

Time to Exit (Years): 6.1

Date Filed: 06/23/2014

Date Issued: 07/23/2014

Offer Price (USD): $12.00

First Day Closing Price (USD): $12.05

No. of Shares Offered + Overallot Sold All Mkts: 5,000,000

Proceeds Amt + Overallot Sold All Markets (USD Mil): $60.00

Post Offer Value (USD Mil): $186.26

Issuer’s Legal Advisor: Hogan Lovells US LLP

Book Runner: Jefferies & Co Inc, Leerink Partners LLC

Source: Thomson Reuters and company prospectus